SuperworthHyperfine market cap HYPR
Share price times shares outstanding: what the whole company sells for, since 2021.
- Today, Oct 23, 2026
- $76.8M
- Highest close in our data
- $274.3M
- Apr 2022
Hyperfine is worth $76.8M at the close on Oct 23, 2026, at $0.72 a share.
That is down 24% over the last year and down 71% over five years.
Its highest close in our data was $274.3M in Apr 2022.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $76.8M | $76.8M | $183.2M | −25% |
| 2025 | $103M | $42.4M | $137.5M | +59% |
| 2024 | $64.9M | $56.8M | $87.1M | −19% |
| 2023 | $80.2M | $60M | $211.1M | +35% |
| 2022 | $59.3M | $54.4M | $274.3M | −69% |
| 2021 | $192M | $192M | $264.4M | n/a |
Against its peers
Companies in Healthcare nearest Hyperfine's size, closest first, today.
| Company | Market cap |
|---|---|
| HYPRHyperfine | $76.8M |
| LFVNLifevantage | $73.4M |
| SPROSpero Therapeutics | $64.6M |
| ICCCImmucell | $93.1M |
| KEQUKewaunee Scientific | $94.9M |
| APTAlpha Pro Tech | $56.7M |
| ATNMActinium Pharmaceuticals | $47.8M |
| NEPHNephros | $38.3M |
| PDEXPro DEX | $199.3M |
| PLXProtalix BioTherapeutics | $205.5M |
| NATRNatures Sunshine Products | $213.8M |
| Peer median | $83.3M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Hyperfine
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.